Further, to characterize the potential correlation between prognosis and AHR–IDO–KYN signaling clinically, the mRNA expression of these genes and the level of KYN in 50 BCP-ALL samples were examined. This evidence concerns the gene IDO1 and acute lymphoblastic leukemia.